Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study

…, C Thalamas, F Ory-Magne, T Slaoui… - Journal of Neurology …, 2007 - jnnp.bmj.com
Background: Patients suffering from Parkinson's disease (PD) describe painful sensations
that could be related to neuropathic pain. Experimental data have indicated the involvement …

Comparison of intravenous alteplase with a combined intravenous–endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE …

…, E Meseguer, PC Lavallée, L Cabrejo, T Slaoui… - The Lancet …, 2009 - thelancet.com
Background The efficacy of intravenous (IV) alteplase is restricted by the speed of
recanalisation and the site of the occlusion. The aim of this study was to ascertain the effect …

Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic review

…, M Mazighi, J Labreuche, C Arnaiz, L Cabrejo, T Slaoui… - Stroke, 2009 - Am Heart Assoc
Background and Purpose—The natural history of stroke is worse in women than in men.
Controversial data have been published on the efficacy of thrombolysis with recombinant …

Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy

…, P Payoux, F Ory, A Sommet, T Slaoui… - Annals of …, 2007 - Wiley Online Library
We conducted a randomized, double‐blind, placebo‐controlled, single‐patient (N= 1) trial to
evaluate the efficacy of zolpidem in a 48‐year‐old woman with an akinetic mutism. Motor …

Yield of systematic transcranial Doppler in patients with transient ischemic attack

…, L Cabrejo, JM Olivot, H Abboud, T Slaoui… - Annals of …, 2010 - Wiley Online Library
Objective Urgent evaluation and treatment of transient ischemic attack (TIA) patients in a
dedicated TIA clinic may reduce the 90‐day stroke risk by 80%. ABCD2 (Age, Blood …

Does ABCD2 Score Below 4 Allow More Time to Evaluate Patients With a Transient Ischemic Attack?

…, PC Lavallée, E Meseguer, L Cabrejo, T Slaoui… - Stroke, 2009 - Am Heart Assoc
Background and Purpose—The National Institute for Clinical Excellence (NICE)
recommends that patients with a transient ischemic attack and ABCD2 score≥ 4 and those …

Safety and tolerability of growth hormone therapy in multiple system atrophy: a double‐blind, placebo‐controlled study

…, A Cardozo, N Dizdar, O Rascol, T Slaoui… - Movement …, 2007 - Wiley Online Library
The objective of this study was to investigate tolerability and possible neurotrophic effects of
growth hormone (GH) in treatment of multiple system atrophy (MSA). In this double‐blind …

Prospective validation of Canadian TIA Score and comparison with ABCD2 and ABCD2i for subsequent stroke risk after transient ischaemic attack: multicentre …

…, N Chagnon, E Shouldice, C Atzema, T Slaoui… - bmj, 2021 - bmj.com
Objective To validate the previously derived Canadian TIA Score to stratify subsequent
stroke risk in a new cohort of emergency department patients with transient ischaemic attack …

Levodopa modifies pain thresholds in Parkinson's disease patients

T Slaoui, A Mas-Gerdelat, F Ory-Magne… - Revue …, 2007 - europepmc.org
[Levodopa modifies pain thresholds in Parkinson's disease patients]. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

Predictors of neurologists confirming or overturning emergency physicians' diagnosis of TIA or stroke

…, N Chagnon, E Shouldice, C Atzema, T Slaoui… - Canadian Journal of …, 2021 - Springer
Background Transient ischemic attack (TIA) and non-disabling stroke are common
emergency department (ED) presentations. Currently, there are no prospective multicenter …